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Conclusion: Late ISR is not rare and accounts for 19.48% of restenosis cases. However 
the determinants of late ISR appear to be similar to those of early ISR. Randomized clin- 
ical trials studying ant&stenosis strategies should include analysis of late outcomes. 
L: 6 months t 12 months P 
Stent Volume (mm) 170.57 +/- 72.09 144.21 J- 57.46 0.4 
IH Volume (mm>) 65.73 +I- 31.13 56.74 +I- 28.13 0.5 
IH Volume (mm>)/StentVolume(mmz) ,384 +f- ,079 .393+/-,115 0.8 
20 mm but < 50-mm). Patients were randomized Into 2 different PCI strategies: POBA 
with provisional stenting (n=64) vs. STENT (n=84). Angiographic restenosis was deter- 
mined at 9 months follow-up and data was analyzed by intention to treat. 
Results: there were no significant differences in age (62~8 vs. 62+9) and incidence of 
diabetes (13.7% vs. 14%) between the STENT and POBA groups respectively. Provi- 
sional stenting for suboptimal result or limiting flow dissection was required in 15164 
(24%) of patients in the POBA group. Angiographic results follow: 
POBA (n=64) STENT (n=64) P-Value 
1052-182 Coronary Angioplasty With Stenting Preceding Major 
Noncardiac Surgery: When Is It Safe to Operate? 
Aivind K. Sharma, Andrew E. Ajani. Parimal Maniar, Shilen Lakhanr. Joseph Lindsay, 
Ron Waksman, Washington Hospital Center, Washington, DC 
Background: The optimal timing of PCI with stenting preceding high-risk elective non- 
cardiac surgery is unknown. The aim of this study was to assess clmical outcomes in 
patients (pts) who had coronary stenting within 90 days of non-cardiac surgery 
Methods: We analyzed 47 pts undergoing elective major non-cardiac surgery within 90 
days of coronary stent placement (January 1995.December 2000). Records were ana- 
lyzed for occurrence of myocardial infarction, major and minor bleeding, death, and anti- 
platelet therapy use during the peri- and postoperative period. 
Results: Of the 47 pts (52% male, 43% diabetics, 66% hypertensives), 15 pts (32%) had 
vascular surgery (including thoracic or abdominal aneurysm repair, carotid endarterec- 
tomy) and 18 pts (38%) had abdominal surgery (including colectomy, cholecystectomy). 
Perioperatively, 6 pts (13%) had minor bleeding and 2 (4%) had non-fatal major bleeding 
(retroperitoneal and intracranial); the majority (6/8) were on anti-platelet therapy at the 
time of surgery. Four pts (9%) had a Ml (2 QMls) within 4 days of surgery (Table). Six pts 
(13%) died (all cardiac), of whom 5 had surgery within 21 days of stenting and were not 
on anti-platelet therapy. 
Conclusion : Elective major non-cardiac surgery should be deferred for a minimum of 4 
weeks after PCI (with stentmg) to prevent stent thrombosis. 
Patient Death Ml Time PCI to surgery (days) Time surgery to event (days) 
1 Yes Yes 17 1 
2 Yes No 1 12 
3’ Yes No 2 10 
4 Yes No 21 4 
5 YSS Yes 7 4 
6 Yes No 67 5 
7 No Yes 71 2 
8 No Yes 72 2 
‘On antiplatelet therapy at surgery 
1052-l 83 Persistent Benefit of Coronary Artery Stenting Versus 
Balloon Angioplasty for Isolated Stenosis of the 
Proximal Left Anterior Descending Coronary Artery: 
Five-Year Clinical Follow-Up 
Francesco Versaa, Achille Gaspardone, lgino Proietti, Fabrizio Tomal, Jacob Zeitani, 
Anna De Fazio, Filippo Crea, Francesco Romeo, Pier Agostino Gioffrh, Luigi Chiariello, 
Universita di Roma Tor Vergata, Roma, Italy 
We have previously demonstrated that in a trial that carried out 120 symptomatic patients 
(pts) with isolated stenosis of the proximal leff anterior descending coronary artery, pri- 
mary stent implantation, as compared with balloon angioplasty (PICA), resulted in bener 
clinical and angiographic results at one year. The aim of this study was to establish 
whether the early favourable results are maintained over 5-year follow-up. 
Data at five years were determined from hospital-wide clinical database. Major clinical 
events (death, myocardial infarction, and target lesion revascularization) were analysed 
according to the intention to treat analysis. 
A trend towards a higher total and cardiac mortality was observed in patients treated with 
PTCA compared those treated with stent (17% YS 7% and 13% vs 5%); non fatal myocar- 
dial infarction was not significantly different in the 2 study groups (8 vs 5%, p=O.46). In 
the PTCA pts, 21% underwent target lesion revascularization (TLR) versus 9% of pts in 
stent group (p=O.O14). At five years, the event-free survival rate (80 vs 53%; p=O.O034) 
was significantly bener in stent group compared with PTCA. 
Conclusions. In patients with isolated stenosis of the proximal left antenor descending 
coronary artery, five years clinical follow-up confirms a better clinical outcome in stent 
compared with PTCA group. 
1052-184 Randomized Trial of Balloon Angioplasty Versus 
Stenting for the Treatment of Long Coronary Lesions 
Alfred0 Rodriguez, Alexandre A. Abizald, Rafael Moguel, Willlam Tones, Carlos 
Fernandez, Vinicius Vsz. Maximo Rodriguez, Rodolfo Staico. Fausto Feres, Jose 
Eduardo M. Sousa, laor F. Palacios, Massachusetts General Hospital, Boston, MA 
Background: percutaneous coronary interventions (PCI) of long lesions remains an 
important challenge in interventional cardiology, as it is associated v&h increased com- 
plications and restenosis rate. Balloon angioplasty (POBA) has limited efficacy in these 
patients. Although coronary stenting (STENT) has been demonstrated to improve both 
immediate and long-term results after PCI. lesson length is a strong predictor of resteno- 
sis after stent implantation, Thus, the question of how best treat patients with long coro- 
nary lesions remains unanswered. Methods: we compared the incidence of angiographic 
restenosis between POBA and STENT in 128 patients undergoing PCI of long lesions (Z 
Reference Diameter 
MLD Pre 
MLD Post 
MLD Follow-up 
Acute Gain 
Late Loss 
Net Gain 
Restenosis 
2.9 2.9 
* 0.3 * 0.4 
0.87 0.8 
* 0.27 + 0.25 
2.3 2.65 
* 0.44 * 0.43 
1.59 1.82 
* 0.8 * 0.4 
1.44 1.85 
* 0.35 * 0.4 
0.68 0.83 
* 0.55 * 0.84 
0.77 1.05 
f 0.52 * 0.65 
28/61 (45.9%) 17161 (27.4%) 
0.2 
0.03 
0.04 
Conclusions: A strategy of coronary stenting is superior to one of POBA and provisional 
stenting for the treatment of long coronary lesions. It results in larger post-PC1 MLD and 
lower incidence of angiographic restenosls at follow-up. 
NS 
NS 
0.0003 
0.15 
0.00006 
1052-l 85 A Mathematical Model of Preventing Plaque Rupture 
With Drug-Eluting Stents Based Upon Distance From 
the Ostium to the Culprit Lesion in ST Elevation 
Myocardial Infarction 
Aiay J. Kirtane, Sabina A. Murphy, Juhana Karha, Graham C. Wong, Robert P. 
Giugliano. Elliott M. Antman, C. Michael Gibson, The TIMI Study Group, Brigham 8 
Women’s Hospital, Boston, MA 
Background: In so far as drug eluting stents are associated with low rates of restenosis 
and formation of a stable intima, we evaluated how far down the coronary artery one 
would need to place a stent to theoretically minimize the risk of plaque rupture associ- 
ated with ST elevation MI (STEMI). Methods: Distances from the ostium to the end of 
the culprit lesion were planimetered in 1,914 STEMI patients enrolled in the TIMI 14, 20. 
23 and 24 trials. Distances include the length of the left main. Results: 75% of culprit 
lesions lay within the first 60 mm of the coronary ostia. The mean distance from coronary 
ostium to the end of the culprit lesion was 50.3 * 33.7 mm (median=42.9, IQ range=31.8/ 
60.2) and the relative distance from ostium to the end of the lesion was 32.8 f 18.9% 
(median=28.8%, IQ range=21.3/39.9) of the total culprit artery length. Diabetes was the 
only baseline characteristic associated with a greater distance to the end of the lesion. 
The shortest ostium to lesion distances were found in LAD lesions (44.0 f 26.1 mm, 
median=40.1, IQ range=29.9/51.9) followed by circumflex lesions (48.1 f 22.9 mm, 
medianc43.0, IQ range=31.8/61.9) and RCA lesions (58.4 r 40.0 mm, median=47.0. IQ 
range=33.6/70.3, 3 way p<O.OOOl for the 3 arteries). Conclusion: The major@ of STE- 
MIS occur in the proximal one third of the major coronary arteries. Cumulative distribution 
functions are presented (figure) to allow estimation of the percent of culprit lesions lying 
proximal to any given distance to model the feasibility of this approach. 
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